Analysis Level of Serum Estradiol Hormone of Pregnant Women with Melasma by Anis Irawan Anwar, Anis Irawan Anwar
 American Journal of Clinical and Experimental Medicine 
2016; 4(2): 26-29 
http://www.sciencepublishinggroup.com/j/ajcem 
doi: 10.11648/j.ajcem.20160402.13 
ISSN: 2330-8125 (Print); ISSN: 2330-8133 (Online)  
 
Analysis Level of Serum Estradiol Hormone of Pregnant 
Women with Melasma 
Andi Miranti
1
, Anis Irawan Anwar
1
, Khairuddin Djawad
1
, Ilhamjaya Patellongi
2
,  
Siswanto Wahab
1
, Nusratuddin Abdullah
3 
1Department of Dermatology, Medical Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia 
2Faculty of Public Health, Hasanuddin University, Makassar, South Sulawesi, Indonesia 
3Department of Obstetric and Ginecology, Medical Faculty, Hasanuddin University, Makassar, South Sulawesi, Indonesia 
Email address: 
miranti_rm@yahoo.com (A. Miranti), anisianwar@yahoo.co.id (A. I. Anwar), duddin@ymail.com (K. Djawad),  
siswantowahab@ymail.com (S. Wahab), ilham_pt@yahoo.com (I. Patellongi), nusraya@yahoo.com (N. Abdullah) 
To cite this article: 
Andi Miranti, Anis Irawan Anwar, Khairuddin Djawad, Ilhamjaya Patellongi, Siswanto Wahab, Nusratuddin Abdullah. Analysis Level of 
Serum Estradiol Hormone of Pregnant Women with Melasma. American Journal of Clinical and Experimental Medicine.  
Vol. 4, No. 2, 2016, pp. 26-29. doi: 10.11648/j.ajcem.20160402.13 
Received: February 15, 2016; Accepted: February 29, 2016; Published: March 21, 2016 
 
Abstract: Hormonal changes in pregnancy are the important etiology of melasma. The presence of melasma in more than 
75% of pregnancies. At the end of pregnancy, estrogen levels increase. Estrogen, especially estradiol triggers increased 
synthesis of melanin. This paper is aimed to determine the relationship between estradiol hormone with melasma and the type 
ofmelasma in pregnant women. This study used a cross-sectional study design to determine the relationship of estradiol 
hormone with melasma. It was conducted from September-November 2015. Skin examination was performed on 64 pregnant 
women (15-49 years old) who suffered from melasma in the third trimester and who did not, and the blood was drawn to 
measure the level of serum estradiol hormone. The study results that the levels of estradiol was slightly higher in women with 
melasma than those without melasma (13811.7 vs 12820.5), but not statistically significant (p>0.05). There was slightly higher 
levels of estradiol in women with the mixed type of melasma than the other types (14444.10 vs 14047.25 and 12243.50), but it 
was not statistically significant (p>0.05). Estradiol levels correlated significantly (p<0.05) with maternal age (r = 0.238) and 
gestational age (r = 0.435); but did not correlate significantly (p>0.05) with MASI (Melasma Area Severity Index) score and 
the type of melasma. The study concluded that estradiol levels in women with melasma are higher than not melasma and in 
mothers with type mix melasma were higher than other types, but not statistically significant. Estradiol level correlated with 
maternal age and gestational age. 
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1. Introduction 
Melasma is a common pigmentary disorder that manifests 
as symmetric hyperpigmented macules and patches on the 
face. It typically affects women of reproductive age with 
Fitzpatrick skin type IV-VI. [1] 
The etiology of Melasma is multifactorial such as 
pregnancy, sun exposure, hormonal therapy, the use of 
cosmetics, racial or genetic effects, phototoxic drugs and 
antiseizure. The majority of melasma cases is associated with 
sun exposure, pregnancy or oral contraceptives. [2, 3] 
In melasma pigmentation occurs as a result of increased 
production of melanin or the increased proliferation of active 
melanocytes. Increased production of melanin have occurred 
without changes in the number of melanocytes. Mechanism 
incidence of melasma occurring in a formation process of 
melanin, melanosomes production may increased, increased 
melanisasi melanosomes, the formation of larger 
melanosomes, the increase in transfer of melanosomes from 
melanocytes to keratinocytes, as well as increased durability 
of melanosomes in keratinocytes.[4] 
In pregnancy, particularly in the third trimester, there is 
stimulus for melanogenesis, and the increased levels of 
placental, ovarian and pituitary hormones may justify the 
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association between melasma and pregnancy. [5] 
Hormonal changes are also important etiologies. In 
particular, the presence of melasma in up to 75% of 
pregnancies, the increased incidence of the disease in 
women on oral contraceptive pills (OCP), the histological 
finding of increased estrogen receptor expression in 
affected skin, the strong correlation between estradiol levels 
and melanogenesis, and the association of melasma with 
hormone replacement therapy in post-menopausal women 
all support this theory [6] Athar Moin et al, found that 
pregnant women who suffer from melasma is more 
common in third trimester and the higher parity, melasma is 
also increasing. [7] 
Estradiol levels regarded as estrogen levels with the 
highest potential to melanogenesis, melanositosis, and 
deposition of melanin pigment. [8] 
Wiedemann et al. (2009), conducted the research on the 
analysis of differences in the effects of progesterone and 
chlormadinone acetate (CMA) in melanocytes compared to 
estrogen. Obtained melanocyte proliferation induced by 17β-
estradiol (0.1 and 1 nM) in about half of the experiment, 
whereas progesterone (100 nM) and CMA (100 nM) reduced 
the proliferation rate respectively 38% and 27%. Activity 
pigmentation slightly stimulated by 17β-estradiol, while 
progesterone has no effect on the activity of tyrosinase. [9] 
Based on the above research, a study is needed to see the 
extent of the relation between the levels of the estradiol 
hormone to melasma and type of melasma. 
2. Patients and Methods 
This study used a cross-sectional study design. Selection 
of sample was performed in consecutive sampling. The 
Research was conducted at the Antenatal Care Clinic of 
RSIA Siti Fatimah, Ujung Pandang Baru health center, Kassi-
Kassi health center. The Examination was carried out in the 
Laboratory of Microbiology Hospital UNHAS during the 
period of September to November 2015. Thirty-two patients 
were third trimester pregnant women aged 15-49 years who 
were diagnosed with melasma and 32 pregnant women who 
did not suffer from melasma as the control group. Patients 
who experienced post-inflammatory hyperpigmentation, 
were taking medications that are phototoxic, suffering from 
thyroid disease, and who refused to participate were excluded 
from the study. 
The research subjects were given a description of the 
research to be carried out; if they were willing to participate 
in research, they were asked to sign an informed consent. The 
patients were further selected according to the inclusion and 
exclusion criteria. The data collection performed, covering 
the history, physical examination, and picture taking using 
the camera canon ixus 130 14.1 megapixels, usual lighting, 
and dark blue background. The patients were then examined 
in order to differentiate between the epidermal, dermal and 
mixed type of melasma with the use of wood's lamp. 
Examination to differentiate melasma and post-inflammatory 
hyperpigmentation by using the dermoscopic tool was carried 
out using anhandyscope connected with iphone 4S. After 
that, the patients had their blood taken from the vena cubiti as 
many as 3 cc, which then stored in the blood bank. After all 
the samples were collected, it was examined for the hormone 
estradiol serum using ELISA method. 
A Descriptive analysis and distribution of serum estradiol 
hormone levels were conducted. The data was analyzed by 
using the Statistical Package for Social Science (SPSS). 
Statistical test used are the correlation of Spearmen test and 
Mann Whitney U test with significance level p<0.05. 
3. Result 
Table 1. Comparison of estradiol levels between mothers with and without 
melasma. 
Melasma 
Estradiol Level(pg/mL) 
Value p* 
Min/Maks Mean (SD) Median 
Yes (=32) 6382,5/18874,1 
13319,52 
(3081,39) 
13811,7 
p= 0,128 
No (n=32) 389,1/18728,0 
11924,76 
(4078,81) 
12820,5 
*Mann Whitney 
In table 1 show that the estradiol level was slightly higher 
in women with melasma than without melisma (Median; 
13811.7 vs12820.5), but it was not statistically significant 
(p>0.05). 
Table 2. Comparison of estradiol levels based on the type of melasma in 
women with melasma. 
Type of 
Melasma 
Estradiol Level(pg/mL) Value 
p* Min/Maks Mean (SD) Median 
Epidermal 
(n=12) 
6382,5/15900,2 
12414,16 
(2851,18) 
14047,25 
p=0,441 Dermal (n=6) 7599,3/16014,3 
13132,18 
(3463,16) 
12243,50 
Mixed (n=14) 8497,7/18874,1 
14175,84 
(3096,43) 
14444,10 
*Kruskal Wallis test 
Table 2 present there were slightly higher levels of 
estradiol in women with the mixed type of melasma 
compared to the other types (Median; 14444.10 vs 14047.25 
and 12243.50), but it was not statistically significant 
(p>0.05). 
Table 3. Correlation of maternal age, gestational age, MASI scores and type 
of melasma with estradiol levels. 
Variable 
Estradiol Level(pg/mL) 
n R Nilai p* 
Age (year) 64 r = 0,238 p=0,012 
Gestational age (month) 64 r = 0,435 p<0,001 
MASI Score 32 r = 0,187 p=0,153 
Type of Melasma 32 r = 0,230 p=0,103 
*Spearmann Correlation 
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Table 3 shows that estradiol levels correlated 
significantly (p<0.05) with maternal age (r = 0.238) and 
gestational age (r = 0.435); but did not correlate 
significantly (p>0.05) with MASI score and type of 
melasma. 
4. Discussion 
This study chose estradiol hormone as its subject, as it is 
one of the most active forms of estrogen associated with the 
appearance of melasma, based on previous research and 
supporting journals which showed that estrogen increases the 
activity of tyrosinase and the number of melanocytes. [10] 
High estrogen levels in serum have been reported to be 
associated with increased skin pigmentation. However, it is 
not clear whether the sex hormones play an important role 
in the proliferation of melanocytes from human culture and 
the activity of its tyrosinase [11]. In this study (Table 1) we 
obtained that the estradiol levels are slightly higher in 
women with melasma than women without melasma 
(median; 13811.7 vs 12820.5), but it was not statistically 
significant (p>0.05). 
During pregnancy there is an increase in estrogen, 
progesterone and MSH, especially in the third trimester, which 
are often found associated with melasma. Estrogen and 
progestin may trigger the hyperpigmentation response by 
stimulating melanogenesis in melanocytes. Tyrosinase activity 
is increased and cell proliferation is reduced after treatment 
with β-estradiol-cultured melanocytes. Sex steroids increase 
gene transcripts for the enzyme of melanogenesis in normal 
human melanocytes, especially for DCT and tyrosinase. These 
results are consistent with an increase in melanin synthesis and 
significant tyrosinase activity. Tyrosinase has been proven 
using estradiol as a substrate for hydroxylate to cathecol-like 
compound which can then regulate its enzymatic activity. 
When melanocytes contain estrogen receptors in its cytosol 
and nucleus, the pigmented cells in melasma patients are more 
sensitive to the stimulatory effect of estrogen and other sex 
steroid hormones. The existence of a second estrogen receptor 
(ERβ) in human skin has a certain role that is different from 
the classical estrogen receptors (ERα), which has the potential 
to increase the diversity in the mechanism of action of 
estrogen. [12] During the later stages of pregnancy the mother, 
placenta, and fetus collaborate to make large amount of 
steroids. Steroids are produced in a relatively larger amount 
isestriol. [13] 
The production of estrogen by the placenta depends on 
precursors in the circulation, but in this situation either fetal 
or maternal steroids are important sources. Most estrogens 
derived from fetal androgens, particularly DHEAS. 
Dehydroepi androsterone sulphate fetus produced mainly by 
the adrenal fetus, the placenta converted by a sulfatase into 
DHEA, and further through enzymatic pathways common to 
steroid-producing tissues into androstenedione and 
testosterone. These androgens finally experienced 
aromatization in the placenta becomes consecutive estrone 
and estradiol. Most of DHEAS fetal is metabolized to a third 
estrogen form that is an estriol. [13] 
There are two subtypes of estrogen receptor and several 
isoforms and variants of each subtype connection. The first 
subtype, estrogen receptor α (ERα) classic, was first cloned 
in 1986; and the most recent discovery was the second 
subtype, estrogen receptor β (ERβ). ERβ expression is clearly 
visible in the human epidermis, the cells located in the 
stratum basal and stratum spinosum become more 
immunoreactive than in the granular layer, while the stratum 
corneum is not immunoreactive. Strong staining in the 
nucleus for ERβ was also seen in the papillary dermis and 
blood vessels. [14] This may explain the obtained results 
(Table 2) which showed the slightly higher levels of estradiol 
in women with the mixed type of melasma than the other 
types(Median; 14444.10 vs 14047.25 and 12243.50), but it 
was not statistically significant (p>0.05). 
The mechanism of induction of melasma by estrogen may 
be related to the presence of estrogen receptors on the 
melanocytes that stimulate cells to produce more melanin. 
[15] Histologically, women who have this condition develop 
an increased number of melanocytes, with the deposition of 
additional melanin and a background of solar elastosis, 
typically on the cheeks, forehead, and upper lip. [16] 
In this study (Table 3) there was a significant relationship 
between levels of estradiol with gestational age, the mean 
estradiol levels in pregnant women got higher along with the 
more advanced gestational age. Estrogen produced by the 
placenta during pregnancy have higher levels in the second 
and third trimesters. At the end of the third trimester, estrogen 
reached its peak level of 6 ng/ml, which is 30 times higher than 
the concentration at the time of menstruation. [17] 
The study did not examine the levels of the 
hormoneestriol, which is one form of estrogen which are 
relatively many in pregnancy due to lack of funding. 
5. Conclusion 
Estradiol levels in women with melasma are higher than 
not melasma (13811.7 vs 12820.5) and in mothers with type 
mix melasma were higher than other types (14444.10 vs 
14047.25 and 12243.50), but not statistically significant. 
Estradiol level correlated with maternal age and gestational 
age. Further research is needed to prove the effect of 
hormonal melasma (MASI score and the type of melasma) 
with a cohort approach by observing the levels of the 
hormone estradiol in the final trimester I, II, and III as well as 
observing the type of melasma and score serum MASI. 
Abbreviation 
MSH: Melanin Stimulating Hormone 
Melanocortin 1 receptor (MC1-R) 
Tyrosinase Related Protein 1 (TRP-1) 
dopachrometautomerase (DCT) 
keratinocyte growth factor (KGF) 
estrogen receptor α (ERα) 
estrogen receptor β (ERβ). 
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